Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells
Open Access
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (20), 15363-15369
- https://doi.org/10.1074/jbc.275.20.15363
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25Science, 1997
- Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216Science, 1997
- Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.The Journal of cell biology, 1996
- A topoisomerase II-dependent G2 cycle checkpoint in mammalian cellsNature, 1994
- The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cellsLeukemia Research, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Induction of mammalian topoisomerase ii dependent dna cleavage by nonintercalative flavonoids, genistein and orobolBiochemical Pharmacology, 1990
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- DNA topoisomerases as targets for cancer therapyBiochemical Pharmacology, 1985
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985